Form 4: 908 Devices Inc. CFO Joseph H. Griffith IV Acquires Stock Options and Restricted Stock Units

Chief Financial Officer of 908 Devices Inc., Joseph H. Griffith IV, reports acquisition of stock options and restricted stock units.

Summary

• On March 3, 2025, Joseph H. Griffith IV, the Chief Financial Officer of 908 Devices Inc., acquired 59,362 stock options with an exercise price of $1.98.
• These options vest over time, starting February 1, 2026, with one-third vesting immediately and the remaining two-thirds vesting in monthly installments over the subsequent 24 months, contingent upon continued service.
• Griffith also acquired 130,418 Restricted Stock Units (RSUs), each representing a right to receive one share of Common Stock.
• These RSUs vest beginning February 1, 2026, with one-third vesting immediately and the remaining two-thirds vesting in two equal annual installments, also contingent upon continued service.
• The reporting person directly owns 59,362 stock options and 130,418 RSUs.

Sentiment

Score: 7

Explanation: The sentiment is neutral to positive. It reflects standard executive compensation practices, aligning management interests with shareholders. The vesting schedules suggest confidence in the company's future.

Positives

• The acquisition of stock options and RSUs by the CFO aligns his interests with those of the shareholders.
• The vesting schedules incentivize continued service and commitment to the company's long-term success.

Future Outlook

The document does not contain specific forward-looking statements, but the vesting schedules suggest an expectation of continued service by the CFO.

Industry Context

This type of equity compensation is common for executives in publicly traded companies to align their interests with shareholders and incentivize performance.

Comparison to Industry Standards

• Equity compensation packages, including stock options and RSUs, are a standard practice among publicly traded companies, particularly in the technology and life sciences sectors, to attract and retain key executives.
• Companies like Thermo Fisher Scientific, Agilent Technologies, and Waters Corporation also utilize similar compensation strategies for their executive teams.
• The vesting schedules described are typical, with vesting periods ranging from three to five years, often contingent on continued employment.

Stakeholder Impact

• Shareholders: Aligns executive incentives with shareholder value.
• Employees: Demonstrates commitment to retaining key personnel.
• Management: Incentivizes continued service and performance.

Key Dates